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Running Title: CAM in Hospice and Palliative Care
Abstract:
Context. The aim of palliative care is to improve quality of life for patients with serious illnesses by treating
their symptoms and adverse effects. Hospice care also aims for this for patients with a life expectancy of six
months or less. When conventional therapies do not provide adequate symptom management or produce their
own adverse effects, patients, families and caregivers may prefer complementary or alternative approaches in
their care.
Objectives. To evaluate the available evidence on the use of complementary or alternative medicine (CAM) in
hospice and palliative care and to summarize their potential benefits.
Methods. A defined search strategy was used in reviewing literature from major databases. Searches were
conducted using base terms and the symptom in question. Symptoms included anxiety, pain, dyspnea, cough,
fatigue, insomnia, nausea, and vomiting. Studies were selected for further evaluation based on relevancy and
study type. References of systematic reviews were also assessed. After evaluation using quality assessment
tools, findings were summarized and the review was structured based on PRISMA guidelines.
Results. Out of 4682 studies, 17 were identified for further evaluation. Therapies included acupressure,
acupuncture, aromatherapy massage, breathing, hypnotherapy, massage, meditation, music therapy, reflexology,
and reiki. Many studies demonstrated a short-term benefit in symptom improvement from baseline with CAM,
although a significant benefit was not found between groups.
Conclusion. CAM may provide a limited short-term benefit in patients with symptom burden. Additional
studies are needed to clarify the potential value of CAM in the hospice or palliative setting.
Keywords: Complementary therapy, alternative therapy, palliative care, hospice care, symptom management,
review

Introduction
About one-third of American adults have reported use of complementary and alternative medicine
(CAM) including mind and body practices, among many others.1,2 Despite increasing use, and many CAM
therapies lack sufficient, high quality evidence to support their use in the prevention and treatment of diverse
conditions.3 In addition, many health care professionals continue to have inadequate knowledge about CAM
therapies.
CAM therapies have been used in the palliative care and hospice settings for many years, especially in
the United Kingdom. Patients in these settings commonly report a high symptom burden potentially affecting
their quality of life. Distressing symptoms may be related both to the underlying disease, as well as adverse
effects from treatment. As a result, when conventional therapies do not provide adequate symptom relief or
produce additional adverse effects, patients, families, and caregivers may select CAM approaches, especially
near the end of life.
Data from the 2007 National Home and Hospice Care Survey revealed that CAM was offered by over
40% of hospice care providers. About one-quarter of the surveyed patients received some form of a CAM
therapy during hospice care. The therapies most commonly offered by hospice care providers included massage,
supportive group therapy, and music therapy.4 The Hospice and Palliative Nurses Association (HPNA) has also
recognized the prevalence and potential role of CAM in the palliative and hospice setting. The HPNA
encourages the use of licensed and/or certified CAM services to provide holistic end-of-life care.5
With increasing support for CAM, the need for more data on different practices has continued to grow.
A 2000 systematic review assessed the effectiveness of CAM therapies on selected symptoms at end of life. The
authors identified that acupuncture and massage, among others, may provide pain relief while patients with end
stage chronic obstructive lung disease may have less dyspnea from using acupressure and muscle relaxation. 6 In
the almost 20 years intervening, additional studies assessing the potential role of CAM therapies at the end of
life have been published. The purpose of this systematic review was to identify and evaluate new evidence of

CAM therapies in managing common symptoms and improving quality of life in the palliative and hospice
setting.
Methods
Protocol and Registration
The systematic review was conducted in accordance to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement and is registered in the International Prospective Register of
Systematic Review (PROSPERO): CRD42017067375.7,8
Literature Search
A literature search was conducted in four databases including MEDLINE through PubMed,
Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, and Embase, for studies
which assessed the efficacy of a CAM therapy in a palliative or hospice setting. The initial search was focused
on the common symptoms that patients would experience in this setting.
Specific terms were used according to the database’s preferred terminology. Medical subject headings
(MesH) terms, headings, thesaurus terms, and Emtree terms were used for PubMed, CINAHL, PsycINFO,
and Embase, respectively. The search consisted of three base terms, “complementary medicine”, “palliative
care”, “hospice care”, and a specific symptom as a fourth term. “Complementary” was the preferred MeSH term
in PubMed while “alternative” was preferred for Embase, PsycINFO, and CINAHL. Symptoms included
“pain”, “nausea”, “vomiting”, “anxiety”, “cough”, “fatigue”, “insomnia”, and “dyspnea”. All are commonly
reported by patients receiving palliative care, with the majority of patients diagnosed with cancer.6,9 Filters for
study types, date range of January 1999 to May 2016, and English language were applied after entering search
terms to narrow results.
A second search focused on CAM and quality of life at end of life was also conducted to include
multiple symptoms and overall aspects of a patient’s life. In this search, the same initial base terms,

“complementary medicine”, “palliative care”, “hospice care”, were used and the fourth term was “quality of
life”. Table 1 provides an overview of the specific terms used and filters applied according to database.
A third search was conducted using the same search terms and filters for date range and English
language. However, rather than filter for controlled trials, a filter for systematic reviews was applied.
Eligibility
Each author screened results from one assigned database based on title and abstract. To be eligible
for review, controlled trials had to assess the efficacy of a CAM therapy in managing a symptom or quality of
life in patients in a palliative or hospice setting. Systematic reviews were screened using the same eligibility
criteria. Once systematic reviews were identified, their references were screened for additional controlled trials
and systematic reviews that met the inclusion criteria. References of these additional sources were also
screened. Meeting abstracts and quasi-experimental studies were excluded and duplicates were also removed.
Study Selection, Data Extraction, and Analysis
After compiling the full-text articles, all authors independently assessed and scored them
using the Jadad scale for controlled trials. Randomization, blinding, and accountability for study participants are
all factors assessed in the Jadad scale, and account for selection bias, performance and detection bias, and
attrition bias, respectively.10 Studies which received a Jadad score of three or greater were included.
A meeting of the four authors was held to review Jadad scores. Disagreements were resolved by
discussion of the studies and a consensus was subsequently reached. After finalizing selected articles, each
author independently extracted the data which was subsequently verified by the other three authors. The study
design, patient population, CAM intervention, duration of therapy, symptom(s) assessed, outcomes,
measurement tools, and results were assessed.
Of the 3705 unique records identified and screened, 86 full-text articles were analyzed in depth. Of
these, 69 were excluded for reasons such as inappropriate study population, resulting in 17 eligible for inclusion
(Figure 1).

Results
Table 2 summarizes findings from the 17 included studies of CAM interventions in the palliative or
hospice care setting. The studies which met our inclusion criteria assessed mind and body interventions.
Symptoms assessed included pain, nausea and vomiting, dyspnea, anxiety and depression, and quality of life.
Many studies tested for improvement in multiple symptoms, with pain most frequently assessed (n=8).
Sixteen trials enrolled patients with advanced cancer with a few including patients with other diseases and one
enrolling patients with HIV/AIDS. The visual analogue scale (VAS) and Rotterdam Symptom Checklist
(RSCL) were the most commonly used measurement tools. Assessment tools are described in Supplemental
Table 1.
Acupressure
One study assessed the efficacy of acupressure versus sham wristbands in reducing nausea and
vomiting for three days.11 Measurements were recorded every 6 hours while wearing the wristbands. One
patient reported mild swelling as an adverse event. Antiemetics were continued for participants, although the
specific drug and administration time were not documented. The study was a pilot study and evidence of a
difference between study groups was unlikely. The investigators suggested acupressure may be considered as an
adjunct for palliative care patients in controlling nausea and vomiting.
Acupuncture
A pilot study evaluated the efficacy of electroacupuncture versus a palliative care nurse-led supportive
care group for multiple symptoms based on the Edmonton Symptom Assessment Scale (ESAS).12 Acupuncture
points were chosen based on specific symptoms of each patient. The supportive group involved a 20 to 30minute meeting with a palliative care nurse who provided counseling, emotional support, and coping strategies.
Scores were recorded before and immediately after each intervention, and during weekly follow-ups.
Acupuncture improved symptoms immediately after each session. yet ESAS scores increased by the 6-week
follow-up. Right-leg stiffness and a “falling asleep” sensation were the only reported adverse effects. Nurse-led

supportive care improved symptom scores and benefit was seen at 6-week follow-up. Acupuncture may be
feasible as a treatment for symptom reduction with immediate effects; however, its long-term benefits are
uncertain.
Breathing
A study compared the efficacy of one versus three sessions of a complex breathing intervention.13
Participants reported a heavy breathlessness burden, defined by at least a score of 3 out of 10 on the Numerical
Rating Scale (NRS). The group receiving three sessions had a worse baseline score in the mastery domain of the
Chronic Respiratory Questionnaire – Self-Administered Survey (CRQ-SAS) while the other group had a worse
baseline for anxiety. Breathing techniques included breathing training, anxiety management, relaxation, and
pacing or prioritization. Secondary measures included variations of breathlessness reporting such as “average
intensity”, “distress”, and “coping” using the NRS, CRQ-SAS, and HADS. A clinically significant
improvement for worst breathlessness was seen; however, a “usual care” control arm was not included as a
comparison for the intervention. The trial was well structured and replicable, which could warrant larger future
studies.
Hypnotherapy
Two studies assessed hypnotherapy in the palliative care and hospice setting. A crossover study
compared hypnotherapy to standard care on pain measures.14 In addition to hypnotherapy sessions, participants
were taught self-hypnosis to use between treatment sessions. Symptoms were rated using the MYMOP Version
2 (MYMOP2) tool at baseline, week 4, and week 8. In addition to pain, effects on anxiety, insomnia,
depression, headache, and desire to stop smoking were assessed. No study personnel confirmed the usage of
proper technique or adherence to the assigned self-hypnosis, allowing for questions of the quality of the
intervention. Because patients chose their most burdensome symptoms, multiple symptoms were evaluated;
therefore, identifying the specific symptom(s) that hypnotherapy affects may be difficult.

A second study compared the effects of hypnotherapy to standard care on quality of life, anxiety, and
depression.15 Patients rated their symptoms on their first visit and upon completion of the intervention. Missing
RSCL subscale values were substituted using the personal scale mean of the respective respondent if at least
50% of the items on the subscale were completed. Substituting incomplete data would affect the results and the
true efficacy of the intervention would be unclear. Symptom management was conducted with medications and
was not evaluated in depth. Therefore, the effect of hypnosis versus medications on symptoms remains unclear.
Benefit was noted in the hypnosis group and supportive group which suggests that some form of cognitive
intervention may assist patients at end of life with coping.
Massage Therapy Alone
Seven studies have evaluated the efficacy of massage therapy; three were of massage therapy alone,
three of massage combined with aromatherapy, and one assessed massage in combination with meditation.
One study recruited 509 patients with 380 randomized to six 30-minute individualized massage sessions
by a licensed massage therapist or simple touch.16 A similar proportion of patients in both groups previously
received massage therapy; baseline pain scores were also similar between groups. Secondary measurements
include the MPAC mood scale and the McGill Quality of Life Questionnaire. Scores were recorded at baseline,
weeks 1 and 2, and 1.5 weeks after the intervention completion. Two serious adverse events were reported in
the massage group (respiratory infection and gastrointestinal bleed), but were deemed unrelated to treatments.
No control group was included which would have assisted in differentiating a true benefit from massage
therapy. The study is notable because of its large, multisite design and shows some statistically significant
immediate benefits with massage therapy. The short study period may have accounted for failure to detect a
significant difference in sustained, longer term scores.
A Spanish trial evaluated the effects of physical therapy, including massage and exercise, in patients
with advanced cancer.17 Of 92 patients screened for eligibility, 24 were enrolled; three quarters were men and
half had lung cancer. The intervention group received six physiotherapy sessions which consisted of several

massage techniques, mobilization, and local and global exercises performed by a therapist. Pre- and postintervention scores assessed changes in pain while the mood portion of the MPAC and the Memorial Symptom
Assessment Scale (MSAS) evaluated mood. Only 15 patients were assessed in the final analysis. Multiple
techniques were implemented in the massage group and no standardized protocol was available for the trial to
be replicated. Techniques were chosen according to the type of cancer, which may warrant further study into
specific massage techniques to provide optimal symptom control.
Another study compared a standardized massage or usual hospice care.18 During enrollment, none of the
participants reported receiving massage therapy. All staff were blinded to subject group assignment except for
the person who received eligibility forms and a social worker who scheduled the massage therapists. Although a
standardized protocol for massage was created, sessions were still individualized and the duration varied from
30 to 50 minutes. After the intervention, a few subjects reported receiving previous massage therapies prior to
enrollment. Several subjects received additional massage sessions in between the study sessions. While the
study did not report a significant difference with individuals receiving additional massages, the quality of the
study intervention is questionable. The results may have been affected as a result of receiving more sessions and
from an unknown source.
Massage and Aromatherapy
A single-blinded study evaluated the long-term benefits of aromatherapy massage with lavender oil
versus massage with an inert oil versus no massage.19 Enrollment fell short of the 15 patients needed in each
study arm to detect a 2.3-point difference on the VAS. Six patients withdrew as a result of death or feeling
unwell. Groups were similar at baseline except the massage only group had a significantly higher RSCL score.
Analyses were performed for the three study groups and an additional combined aromatherapy and massage
group. The combined aromatherapy and massage group was not included as an initial study group to which
participants were randomized. While not mentioned in the methodology section, results from the combined
group were presented in the analysis; this is an important consideration when evaluating the analyses.

Another pilot study tested the feasibility of aromatherapy massage in patients with cancer. Of 46
patients recruited from a palliative day care center, 29 completed the trial.20 The aromatherapy massage and
control groups had similar mean performance status scores of 1.4 and 1.3, respectively. Six patients in the
control group were taking antidepressants compared to none in the aromatherapy massage group. Adverse
effects were limited to a rash following massage. A high withdrawal rate impacts assessment of the intervention
and larger studies are needed.
Aromatherapy massage versus massage with an inert oil were compared for their effect on anxiety and
quality of life.21 At baseline, patients randomized to aromatherapy reported poorer quality of life compared with
those in the massage group. Quality of life (QoL) was measured at baseline and one week after the last massage
was administered. Anxiety scales were administered before and after each massage. Significantly greater
improvement in RSCL subscales was noted for the aromatherapy group, despite a poorer baseline QoL. Further
study into the specific essential oil used may be warranted to determine the impact on symptom improvement.
No entry criteria were required for the study and a control group was not used. The lack of a control group is
important as each modality has yet to be proven beneficial as individual treatments.
Massage and Meditation
A study evaluated both meditation and massage for improving QoL near end of life.22 A total of 106
patients were screened with 58 randomized to one of four groups. Despite randomization, baseline
characteristics in the study groups varied. The standard care group had higher mean viral load while the
combined meditation and massage group had the highest CD4 count. Differences in baseline characteristics
could affect the results of the interventions depending on patient health status. Responses were recorded at
baseline, at the end of weeks 2 and 4 during the intervention period, and 1-month after the intervention (week
8). The combined meditation and massage group demonstrated the greatest overall improvement even after
multivariate adjustment for baseline differences. However, because the combined group had a higher CD4 count

and a lower viral load at baseline, the results may reflect better participant disease control in comparison to the
other groups.
Music Therapy
A palliative care team analyzed 198 patients with advanced, life-limiting illness.23 The music therapy
group received 20-minute music therapy sessions performed by a music therapist. Each music therapy session
was individualized, although a standardized framework for the sessions was implemented. The control group
received the same comfort measures as the music therapy group during the session; however, a music therapist
was not present. Both groups had similar baseline characteristics. Pain was assessed at pre- and postintervention. Although 20 minutes was allotted, a few accounts of up to 50 minutes were noted. As a result, the
timing of the post-intervention score also varied. Blinding was broken for a few patients because participants
revealed their group assignment to the research assistant. Only immediate effects were studied, so the long-term
benefits are unknown.
In an Australian study, 25 patients were recruited from inpatient hospice services.24 Only age, sex, and
diagnosis were reported for baseline characteristics. Music session length varied from 20-40 minutes and any
sessions outside of the study’s session duration were not included in the data. Therefore, data could be missing
that would affect the overall results. Only pre- and post-intervention scores were recorded so only short-term
effects were assessed. Patients in the control group continued to receive music therapy outside of the study,
making it unclear if the control group was a true control with no pre-exposure to music therapy. Both studies
showed music therapy improved symptom burden; participants requested and continued receiving music
therapy outside of the studies.
Reflexology
Two studies assessed the efficacy of reflexology in improving QoL. One study randomized 12 patients
receiving palliative care to receive reflexology or placebo.25 Interventions were carried out on days 1, 3, and 5;
assessments using the VAS were recorded at baseline and after the intervention. Multiple symptoms were

assessed including appetite, breathing, communication, constipation, pain, and tiredness. Although the
reflexologist could avoid reflexology points to simulate “placebo reflexology”, some skill may still remain in
providing patients relief through a foot massage. Overall, patients reported an improvement in QoL, but with
the short duration and small population, the generalizability of the study to other care centers is difficult.
In the second trial, patients who were not receiving active cancer treatment were recruited to receive
reflexology or foot massage.26 Seventeen patients were included in the analysis. Participants and interviewers
were blinded to the intervention. “Placebo” foot massage may have provided some level of relief for the
patients. Neither group demonstrated significant improvement in mood and the study failed to demonstrate
superiority of reflexology over foot massage. Foot discomfort was the predominant adverse effect, along with
nausea, shaking, and sleep disturbances. Both studies used foot massage as a placebo”, but the benefit of
massage alone may have occurred.
Reiki
One trial assessed reiki for improvement in pain and QoL.27 Of 73 patients screened for eligibility,
24were enrolled. Participants received varying amounts of opioids, but were all considered to be opioid tolerant
as defined by having a dose increase of over 5% per day. Eleven patients were taking less than 60 mg of
morphine per day, eight received between 60-300 mg/day and five were taking over 300 mg/day. Primary
outcome measures were assessed on days 1 and 4. Quality of life was assessed using ESAS. The use of
objective outcome measures could provide more evidence if a placebo effect was present. Although no
difference was found between the two groups, the study was practical because it also assessed conventional
treatment. Reiki as an adjunct to opioid therapy warrants further study with a larger cohort and longer study
period.
Discussion
This systematic review of randomized controlled trials was conducted to evaluate the newer evidence
available since the 2000 publication by Pan and colleagues.6 The older databases, CancerLIT and AIDS-LINE,

have since been incorporated into MEDLINE, resulting in fewer and more comprehensive databases from
which our searches were conducted. No randomized controlled trials of herbal products or dietary supplements
were identified in the literature search, resulting in the included studies evaluating mind and body CAM. Using
the Jadad scale, we identified higher quality studies on CAM in the palliative or hospice setting.
Massage therapy, combined with aromatherapy, meditation, or massage alone, were the most common
CAM assessed in our systematic review. Studies that assessed massage therapy alone and massage combined
with meditation demonstrated improvement in pain and QoL when compared to control. Mixed results were
found in studies with massage with aromatherapy. Two studies reported no significant change in QoL or pain
while the third aromatherapy massage study reported improvement in anxiety. A decrease in anxiety and pain
was observed in patients who received music therapy, although blinding to intervention and additional therapy
sessions were concerns. No difference in QoL or symptom improvement was seen in hypnotherapy trials. Of the
other CAM, reiki produced a significant decrease in pain intensity although one study was underpowered.
This systematic review has several limitations. While we had defined CAM by the National Center for
Complementary and Integrative Health’s definition, variations of the word exist. By exploding each database’s
index terms, the number of terms under “Complementary therapies” or “Alternative therapies”, varied greatly as
well as what was considered “CAM” (Supplemental Figure 1). Potential studies that did not list our index terms
may have not populated in the search results. Our search strategy did not include the term integrative medicine
which has been increasing in use to describe CAM. Excluding this term may have resulted in additional missed
studies.
Our search terms included “palliative care” or “hospice care”. While those enrolled in hospice care
receive palliative care, not all patients receiving palliative care may be near end of life. A few studies included
patients enrolled in palliative care only and no specifications were stated on whether patients were still
receiving active treatment. Therefore, the characteristics of the patient population may vary and affect how
patients may feel or perform overall.

The Jadad scale was used as the evaluation tool to decide which studies to include in the review. Despite
the tool’s simplicity, our authors’ scores were inconsistent at times and differences were resolved through
discussions involving all authors. The reasons for variability in Jadad scores included ambiguity of the studies
and differing opinions. While all studies included scored a three or higher on the Jadad scale, many other
characteristics differed between the articles. For example, one study enrolled a total of eight patients while
another study enrolled 200 patients.11,23
Various study designs were used and what was considered “control” or “placebo” differed among the
studies. Depending on what one considers as “CAM”, the control group of a study may be considered another
CAM. One such example is the reflexology study conducted by Hodgson et al in which the “placebo
reflexology” was a gentle foot massage.26 In addition, by the nature of mind and body CAM, true blinding of
the participants and performers is difficult. Some methods have been developed to provide blinding of CAM
such as sham acupuncture. However, sham acupuncture has mixed results on its reliability as a placebo.28 We
were unable to perform a meta-analysis as a result of the varying measurement tools used by the studies we
evaluated. Additionally, the majority of measurement tools were subjective. A few studies used objective
measurements, such as blood pressure or respiratory rate.20 Not all studies performed statistical analyses and
one study that did reported failure to account for multiple testing.20 In addition, multiple studies assessed quality
of life which encompasses multiple symptoms. As a result, determining what symptoms benefit most from a
CAM intervention is difficult since multiple symptoms were evaluated simultaneously.
Enrollment rates for studies were low despite recruitment periods of a few years in several studies.12 In
addition, as a typical finding in the hospice care setting, many participants withdrew because of poor health or
death. The high withdrawal rate further decreases the small population size and many studies were unable to
provide power calculations to conclude any significance. Taking this into account, some studies had broader
inclusion criteria to recruit as many participants as possible. However, in doing so, a diverse population in
which treatments and demographic characteristics vary greatly among patients resulted. A few studies addressed

concomitant use of drug therapy, but did not specify the drugs used or duration of drug therapy.11,13 Studies
were conducted in multiple countries, such as the United Kingdom or Spain.18,21 The applicability of such
studies should be taken into account as the patient population and treatment modalities may differ depending on
the country. Baseline scores for patients’ reported symptoms also differed between study groups in several
studies, which could affect the results of how well the intervention managed the symptom(s) in question.
Although limitations are apparent, our review identified new studies which show a modest benefit in
improvement of patients’ quality of life and symptoms. Despite few studies reporting statistically significant
changes in symptom improvement, clinically significant changes were documented and patients reported
positive outcomes in interviews and on questionnaires. Adverse effects were uncommon and minor in nature. A
professional in the specific CAM approach was recruited to perform the intervention in multiple studies. The
expertise of the CAM provider is important to ensure the highest quality of CAM is given.
We identified common outcome measures which may be considered for future studies. A possible metaanalysis may be performed if new studies used the same measures. Our work has also identified barriers to
CAM studies which may be taken into consideration, such the lack of a universal assessment tool or accepted
placebo for proper assessment of a CAM. Small patient populations and short study periods are additional
barriers to providing a higher quality study to demonstrate adequate power. A few studies simultaneously
assessed multiple CAM modalities, making it difficult to identify which therapy provides more benefit. For
patients who are interested in CAM, a discussion should be held with their healthcare providers about potential
value and considerations.
Conclusions
Since 2000, additional studies evaluating CAM in the palliative and hospice setting have been published.
This systematic review identified and evaluated pilot studies testing the feasibility of a CAM intervention in the
palliative or hospice setting as well as larger trials of a previously tested CAM. Of the studies reviewed, a
modest short-term benefit was observed in some trials. Future studies should consider a multicenter design to

recruit more patients. One CAM modality should be assessed at a time and a universal tool for evaluating
symptom improvement should be established for consistency. Of the CAM interventions summarized, music
therapy, massage therapy, and reiki had the most potential benefit although all studies had significant
limitations. Continued research is essential to provide the best patient care in hospice and palliative care.
Disclosures
The authors have nothing to disclose and no competing interests. This research did not receive any
specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References:
1. National Center for Complementary and Integrative Health. Use of complementary health approaches in
the U.S. 2012. Available from: https://nccih.nih.gov/research/statistics/NHIS/2012/keyfindings. Accessed June 4, 2017.
2. National Center for Complementary and Integrative Health. Complementary, Alternative, or Integrative:
What’s in a Name? 2016. Available from: https://nccih.nih.gov/health/integrative-health. Accessed June
4, 2017.
3. Ventola CL. Current issues regarding complementary and alternative medicine (CAM) in the United
States: Part 1: The widespread use of CAM and the need for better-informed health care professionals
to provide patient counseling. Pharm Ther 2010;35:461-8.
4. Centers for Disease Control and Prevention. Complementary and alternative therapies in hospice: the
national home and hospice care survey: United States. 2007. Available
from: https://www.cdc.gov/nchs/data/nhsr/nhsr033.pdf. Accessed May 2, 2018.
5. Hospice and Palliative Nurses Association. HPNA Position Statement: Complementary Therapies in
Palliative Nursing Practice. 2015. Available from: http://hpna.advancingexpertcare.org/wpcontent/uploads/2015/08/Complementary-Therapies-in-Palliative-Nursing-Practice.pdf. Accessed
November 12, 2017.
6. Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM. Complementary and alternative medicine
in the management of pain, dyspnea, and vomiting near the end of life: A systematic review. J Pain
Symptom Manage 2000;20:374-87.
7. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic
reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6(7):e1000097. doi:
10.1371/journal.pmed.1000097.
8. Zeng Y, Wang C, Ward KE, Hume AL. Complementary and alternative medicine for management of
symptoms in hospice and palliative care: a systematic review. PROSPERO: CRD42017067375. 2017.
Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017067375.
Accessed November 13, 2017.
9. National Cancer Institute. Palliative care in cancer. 2017. Available from:
https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/palliative-care-fact-sheet. Accessed
June 22, 2017.
10. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is
blinding necessary? Control Clin Trials 1996;17:1–12.
11. Perkins P, Vowler SL. Does acupressure help reduce nausea and vomiting in palliative care patients?
Pilot study. Palliat Med 2008;22:193-4.
12. Lim JTW, Wong ET, Aung SKH. Is there a role for acupuncture in the symptom management of
patients receiving palliative care for cancer? A pilot study of 20 patients comparing acupuncture with
nurse-led supportive care. Acupunct Med 2011;29:173-9.

13. Johnson MJ, Kanaan M, Richardson G, et al. A randomised controlled trial of three or one breathing
technique training session for breathlessness in people with malignant lung disease. BMC Med
2015;13:213. doi: 10.1186/s12916-015-0453-x.
14. Harlow T, Jones P, Shepherd D, et al. Hypnotherapy for relief of pain and other symptoms in palliative
care patients: a pilot study. Contemp Hypn Integr Ther 2015;30:163-174.
15. Liossi C, White P. Efficacy of clinical hypnosis in the enhancement of quality of life of terminally ill
cancer patients. Contemp Hypn 2001;18:145-150.
16. Kutner JS, Smith MC, Corbin L, et al. Massage therapy versus simple touch to improve pain and mood
in patients with advanced cancer: a randomized trial. Ann Intern Med 2008;149:369-79.
17. Lopez-Sendin N, Alburquerque-Sendin F, Cleland JA, Fernandez-de-las-Penas C. Effects of physical
therapy on pain and mood in patients with terminal cancer: a pilot randomized clinical trial. J Altern
Complement Med 2012;18:480-6.
18. Wilkie DJ, Kampbell J, Cutshall S, et al. Effects of massage on pain intensity, analgesics and quality of
life in patients with cancer pain: a pilot study of a randomized clinical trial conducted within hospice
care delivery. Hosp J 2000;15(3):31-53.
19. Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy
massage in a hospice setting. Palliat Med 2004;18:87-92.
20. Wilcock A, Manderson C, Weller R, et al. Does aromatherapy massage benefit patients with cancer
attending a specialist palliative care day centre? Palliat Med 2004;18:287-90.
21. Wilkinson S, Aldridge J, Salmon I, Cain E, Wilson B. An evaluation of aromatherapy massage in
palliative care. Palliat Med 1999;13:409-17.
22. Williams A, Selwyn PA, Liberti L, et al. A randomized controlled trial of meditation and massage
effects on quality of life in people with late-stage disease: a pilot study. J Palliat Med 2005;8:939-52.
23. Gutgsell KJ, Schluchter M, Margevicius S, et al. Music therapy reduces pain in palliative care patients: a
randomized controlled trial. J Pain Symptom Manage 2013;45:822-31.
24. Horne-Thompson A, Grocke D. The effect of music therapy on anxiety in patients who are terminally
ill. J Palliat Med 2008;11:582-90.
25. Hodgson H. Does reflexology impact on cancer patients' quality of life? Nurs Stand 2000;14:33-8.
26. Ross CSK, Hamilton J, Macrae G, et al. A pilot study to evaluate the effect of reflexology on mood and
symptom rating of advanced cancer patients. Palliat Med 2002;16:544-5.
27. Olson K, Hanson J, Michaud M. A phase II trial of Reiki for the management of pain in advanced cancer
patients. J Pain Symptom Manage 2003;26:990-7.

28. Lundeberg T, Lund I, Näslund J, Thomas M. The Emperors sham: wrong assumption that sham needling
is sham. Acupunct Med 2008;26:239–42.

Figures and Tables:
Figures:
•

Figure 1: Flow Diagram of Steps in Systematic Review
o Outlines steps taken and number of studies excluded and included in each step.

•

Supplemental Figure 1: Complementary and/or Alternative Medicine (CAM) Definitions
o Provides examples of therapies according to each database’s definition of CAM

Tables:
•

Table 1: Summary of Search Strategies
o Demonstrates the search strategy used, including search terms and filters used for each database
and the number of results produced

•

Table 2: Summary of Articles Included in Systematic Review
o Outlines characteristics of studies included in the systematic review

•

Supplemental Table 1: Description of Assessment Tools
o Describes various assessment tools that have been validated in literature

Table 1
Summary of Search Strategies and Number of Results
Database

Search Terms

Symptoms + “Quality of life”

Applied Filters

No. Resultsa

MEDLINE (PubMed)

((("Complementary Therapies"[Mesh])
AND ( "Hospice and Palliative Care
Nursing"[Mesh] OR "Palliative
Care"[Mesh] OR "Palliative
Medicine"[Mesh] OR "Hospice
Care"[Mesh])) AND "SYMPTOM"[Mesh])

"Pain"[Mesh]
"Dyspnea"[Mesh]
"Cough"[Mesh]
"Nausea"[Mesh]
"Vomiting"[Mesh]
"Anxiety"[Mesh]
"Sleep Initiation and Maintenance Disorders"[Mesh]
"Fatigue"[Mesh]

Study Types:
Clinical study/trial
Controlled clinical trial
Randomized controlled trial
Systematic reviews
Meta-analysis
Multicenter study
Observational study

140

Date:
1999-2016
CINAHL

(MH "Alternative Therapies+") AND ((MH
"Palliative Care") OR (MH "Hospice and
Palliative Nursing") OR (MH "Terminal
Care") OR (MH "Hospice Care")) AND
(MH “SYMPTOM”)

(MH “Pain+”)
(MH “Dyspnea”)
(MH “Nausea+”)
(MH “Nausea and Vomiting”)
(MH “Vomiting”)
(MH “Anxiety+”)
(MH “Insomnia+”)
(MH “Fatigue+”)

Study Types:
Clinical trial

197

Meta-analysis
Randomized controlled trial
Research
Systematic review

Date:
January 1999-May 2016

Embase

'alternative medicine'/exp AND 'palliative
therapy'/exp OR 'palliative nursing'/exp
AND SYMPTOM/exp

'pain'/exp
'dyspnea'/exp
'coughing'/exp NOT 'pertussis' NOT 'experimental coughing'
'nausea'/exp
'vomiting'/exp NOT 'experimental emesis'
'anticipatory nausea and vomiting'/exp
'chemotherapy induced emesis'/exp
'chemotherapy induced nausea and vomiting'/exp

Study Types:
Clinical trial
Prospective study
Randomized controlled trial

458

'radiation induced emesis'/exp
'nausea and vomiting'/mj
‘anxiety'/exp
‘insomnia'/exp
'fatigue'/exp NOT 'persian gulf syndrome' NOT 'postviral
fatigue syndrome'

Systematic review
Retrospective study

Date:
1999-2016

PsycINFO

SU.EXACT.EXPLODE("Alternative
Medicine") AND
SU.EXACT.EXPLODE("Palliative Care")
OR SU.EXACT.EXPLODE("Hospice")
AND
SU.EXACT.EXPLODE("SYMPTOM")

SU.EXACT.EXPLODE("Pain")
SU.EXACT.EXPLODE("Dyspnea")
SU.EXACT.EXPLODE("Nausea")
SU.EXACT.EXPLODE("Vomiting")
SU.EXACT.EXPLODE("Anxiety")
SU.EXACT.EXPLODE("Insomnia")
SU.EXACT.EXPLODE("Fatigue")

Methodology:
Follow-up study
Meta-analysis
Prospective study
Systematic review
Treatment outcome/clinical
trial

695

Date:
After December 31, 1998May 2016

Table 1. Summary of Search Strategies and Number of Results. This chart demonstrates the search strategy used, including search terms and filters used for each database and the number of
results produced. Included terms are specific to their respective database. A separate search was conducted for each symptom listed. Not all databases included a symptom of interest (i.e. “Cough” was
not a valid search term in CINAHL)
a
=With duplicates removed

Table 2
Summary of Articles Included in Systematic Review
Primary
Author
(Year)
Acupressure

Study Design

Patient Populationa

Interventions

Duration of Study

R, SB, C

• 8 patients with
terminal cancer
• Median age 61
years (range 4874 years)

• Acupressure
wristbands
(P6 pressure point)
(n=3)
• Sham wristbands
(n=5)

3 days

Lim, JTW
(2011)

R, NB, C

• 18 patients with
incurable cancer
• EG: mean age
55 ± 11.1 years
(range 31-72; 8
women, 2 men)
• CG: mean age
64.9 ± 8.7 years
(range 53-81; 7
women, 1 man)

• Acupuncture
(n=10)
• Nurse-led
supportive care
(n=8)

Soden, K
(2004)

R, SB, C

• 42 patients with
advanced cancer
• Median age 73
years (range 4485)
• 32 women, 10
men

Wilcock, A
(2004)

R, NB, C

• 29 patients with
cancer
• EG: mean age
70 years
• CG: mean age
73 years

• Aromatherapy
massage with
lavender oil
(n=16)
• Massage with inert
oil only (n=13)
• No massage
(n=13)
• Aromatherapy
massage with day
care (n=11)
• Day care only
(n=18)

Perkins, P
(2008)

Primary
Symptom(s)
Assessed

4 weeks

4 weeks

Results

• Nausea
• Vomiting

• VAS
• Total antiemetic
doses
• Antiemetic
escalation
• Change in emesis
episodes from
baseline

• No evidence of difference between
two groups for any endpoint
• SSC: 23, 15, and 15 patients needed
in each group to show difference
between change from baseline
emesis, antiemetic doses, and VAS
score

Pain
Tiredness
Nausea
Depression
Anxiety
Drowsiness
Loss of appetite
Lack of
wellbeing
• SOB
• Pain

• ESAS

• Total ESAS scores were reduced by
19% for EG (mean change -0.77
[range -2.75 to 1.5]) and 26% for
CG (mean change -1.69 [range -2.25
to -0.25]) comparing baseline to
week 6 after final intervention
• Only descriptive statistics were used
because of small sample size.

• VAS (primary
endpoint)
• Modified Tursky
Pain Descriptors
Scale
• VSH
• HADS
• RSCL
• MYMOP – Quality
of Life
• POMS – Mood

• No statistically significant changes
in pain from baseline to end of study
for any group
• After second treatment, a reduction
in pain VAS scores in both
aromatherapy (P = 0.03) and
combined massage (P = 0.01) was
observed
• No statistically significant
differences in outcomes between
groups
• Mean difference in slope for POMS
total score -0.4 (95% CI -3.4, 2.5)
• Mean difference in slope for QoL
-0.2 (95% CI -0.6, 0.2)

Acupuncture
4 weeks
(weekly follow-up
for 6 weeks after
final intervention)

Primary Outcome

•
•
•
•
•
•
•
•

• QoL
• Physical
symptoms
• Mood

Wilkinson, S
(1999)

R, NB, C

• 87 patients with
cancer
• Mean age 53.5
years
• 78 women, 9
men

• Aromatherapy
massage with
Roman chamomile
oil (n=43)
• Massage with inert
oil only (n=44)

R, NB, C

• 124 patients with
intrathoracic
malignancy and
breathlessnessb
• One session:
mean age 70 ± 9
years
• Three sessions:
mean age 69 ±
11 years

• One breathing
session (n=43)
• Three breathing
sessions (n=81)

Harlow, T
(2015)

R, NB, CS

• 11 patients with a
primary diagnosis
of cancerb
• Mean age 57 years

Liossi, C
(2001)

R, SB, C

• Hypnotherapy
• Group A (n=9, 4
weeks of
hypnotherapy
then 4 weeks off)
• Group B (n=2, 4
weeks off then 4
weeks
hypnotherapy)
• Hypnotherapy
with standard care
(n=25)
• Standard care only
(n=25)

• Massage therapy
(n=188)
• Simple touch
(n=192)

4 weeks

• QoL
• Anxiety

• RSCL
• STAI

• Pre- and post-test scores for severe
physical symptoms (P < 0.05),
psychological (P < 0.001), and QoL
(P < 0.01) with EG showed
improvement
• Pre- and post-test scores for anxiety
were reduced in both groups (P <
0.0001)

• Breathlessness

• NRS (Worst
breathlessness score)

• Overall decrease in “worst score”
from 6.81 ±1.89 at baseline to 5.84
± 2.39 at week 4
• No between arm differences in
“worst breathlessness” NRS score
between study groups; mean
difference 0.2 (95% CI -2.31, 2.97)
• SSC: 146 participants needed to
determine difference in AUC for
improvement of breathlessness

8 weeks

• Pain

• MYMOP (version 2)

• No significant reduction in pain for
patients who identified pain as
primary symptom
• SSC: 168 patients needed to detect a
meaningful symptom change

4 weeks

• QoL
• Depression
• Anxiety

• RSCL
• HADS

• For both groups, post-intervention
scores improved for all measured
outcomes compared with baseline
• HADS anxiety and depression
scores decreased in the EG
compared with CG (P<0.01)
• RSCL subscales for psychological
distress, physical distress, and
activity level were improved for EG
vs CG (P<0.01)

3 weeks

• Pain

• MPAC (Immediate
pain)
• BPI (Sustained pain)

• MPAC scores showed clinically
significant improved in massage
group (-1.87 points [95% CI, -2.07,
-1.67])

Breathing
Johnson, MJ
(2015)

Hypnotherapy

• 50 patients with
advanced cancer
• Age range 35-74
years

4 weeks
(with a follow-up
at 8 weeks)

Massage Therapy Only
Kutner, JS
(2008)

R, SB, C

• 380 patients with
solid tumors and
metastases

• EG: mean age
65.2 ± 14.4
years
• CG: mean age
64.2 ± 14.4
years

LopezSendin, N
(2012)

R, SB, C

• 24 patients with
terminal cancer
• EG: mean age
55 ± 21 years
• CG: mean age
54 ± 8 years

• Physiotherapy
(n=12)
• Simple touch
(n=12)

2 weeks

• Pain
• Mood

• MPAC (Pain and
mood)
• BPI (Sustained pain)

Wilkie, DJ
(2000)

R, SB, C

• 29 patients with
cancerb
• Mean age 63
years (range 3087)
• 20 men, 9
women

• Massage with
hospice care
(n=26)
• Hospice care only
(n=30)

3 weeks

• Pain
• QoL

• Pain Assessment
Tool
• Skilled Nursing
Visiting Report
Form
• HR
• RR
• Graham QoL Tool

• Aromatherapy
massage with
lavender oil
(n=16)
• Massage with inert
oil only (n=13)
• No massage
(n=13)
• Aromatherapy
massage with day
care (n=11)
• Day care only
(n=18)

4 weeks

• Pain
•

4 weeks

• QoL
• Physical
symptoms
• Mood

• VAS (primary
endpoint)
• Modified Tursky
Pain Descriptors
Scale
• VSH
• HADS
• RSCL
• MYMOP – Quality
of Life
• POMS – Mood

• Aromatherapy
massage with

4 weeks

• QoL
• Anxiety

Massage and Aromatherapy
Soden, K
(2004)

R, SB, C

• 42 patients with
advanced cancer
• Median age 73
years (range 4485)
• 32 women, 10
men

Wilcock, A
(2004)

R, NB, C

• 29 patients with
cancer
• EG: mean age
70 years
• CG: mean age
73 years

Wilkinson, S
(1999)

R, NB, C

• 87 patients with
cancer

• RSCL
• STAI

• EG superior to touch directly after
treatment, but not clinically
significant (mean pain difference 0.90 points [95% CI, -1.19, -0.61])
• For BPI, no statistically or clinically
significant difference between arms
• SSC: 440, assuming 30% attrition,
to detect clinically meaningful
differences between study groups
• No significant group x time
interaction for MPAC mood
differences
• Post-hoc analysis demonstrated
potential improvements in worst and
current pain
• SSC: 12 subjects per group needed
to detect difference in BPI score
• Some significant reductions in HR
and RR after massage sessions
• Reduced pain intensity immediately
after 1st and 3rd massages (P<0.09)
• Reduction in pain was not
significant between study groups.
• No significant differences between
groups for QoL scores
• No statistically significant changes
in pain from baseline to end of study
for any group
• After second treatment, a reduction
in pain VAS scores in both
aromatherapy (P = 0.03) and
combined massage (P = 0.01) was
observed
• No statistically significant
differences in outcomes between
groups
• Mean difference in slope for POMS
total score -0.4 (95% CI -3.4, 2.5)
• Mean difference in slope for QoL
• -0.2 (95% CI -0.6, 0.2)
• Pre- and post-test scores for severe
physical symptoms (P < 0.05),
psychological (P < 0.001), and QoL

• Mean age 53.5
years
• 78 women, 9
men

Roman chamomile
oil (n=43)
• Massage with inert
oil only (n=44)

(P < 0.01) with EG showed
improvement
• Pre- and post-test scores for anxiety
were reduced in both groups (P <
0.0001)

R, SB, C

• 58 patients with
HIV/AIDS
• Meditation:
mean age 45.08
± 2.2 years
• Massage: mean
age 42.81 ± 2.2
years
• Meditation and
massage: mean
age 47.31 ± 2.25
years
• Control: mean
age 45.56 ± 2.24
years
• 43% women

• Meditation only
(n=13)
• Massage therapy
only (n=16)
• Meditation and
massage therapy
(n=13)
• Control (standard
care) (n=16)

8 weeks

• QoL

• MVQOLI

• Combined group improvement for
total score (3.75 ± 1.1 [P<0.05] and
transcendent (5.92 ± 2.06 [P<0.05])
compared to other groups at 8 weeks
• Function score improved in
combined group (19.08 ± 5.48
[P<0.05]) compared to massage and
CG at 8 weeks
• QoL improvements remained after
multivariate adjustment for group
differences at baseline
• SSC: 40 subjects to detect a 5 point
difference on MVQOLI between the
combined and standard care groups

Gutgsell, KJ
(2013)

R, SB, C

• 200 patients with
terminal illness
• EG: mean age
57.45 ± 14.76
years
• CG: mean age
54.72 ± 15.34
years
• 69% women

• Music therapy and
comfort measures
(n=100)
• Comfort measures
only (n=100)

20-50 minutes
(One music
therapy session)

• Pain

• NRS

HorneThompson, A
(2008)

R, SB, C

• 25 patients (24
with cancer)
• EG: mean age
76.2 ± 10.36
years
• CG: mean age
71.4 ± 16.05
years

• Music therapy
(n=13)
• Volunteer led
therapy session
without music
(n=12)

20-40 minutes
(One music
therapy session)

• Anxiety

• ESAS
• HR

• Decline (improvement) from pre- to
post-test NRS for EG (mean change
-1.94 [95% CI -2.37,
-1.52]) and CG (mean change
-0.56 [95% CI -0.92, -0.19])
• Greater decline in NRS score in the
EG (difference in means -1.39 [95%
CI -1.95, -0.83])
• SSC: 100 subjects per treatment arm
to show differences in mean posttest NRS
• Anxiety using ESAS was reduced
for EG (P=0.005), although postintervention data not reported
• No difference between study groups
for anxiety as demonstrated by
decrease in HR (P=0.8)
• SSC: 60 subjects to demonstrate a
difference between groups

Massage and Meditation
Williams, A
(2005)

Music Therapy

Reflexology

Hodgson, H
(2000)

R, SB, C

• 12 patients with
cancer
• Age range 58-80
years

• Reflexology (n=6)
• Gentle foot
massage
(“placebo”
reflexology) (n=6)

5 days

• QoL

• VAS

Ross, CSK
(2002)

R, DB, C

• 17 patients with
advanced cancerb
• Mean age 74
years (range 5785)
• 7 men, 10 women

• Reflexology (n=7)
• Simple foot
massage (n=10)

6 weeks

• Mood

• HADS
• Symptom Distress
Score

R, NB, C

• 24 patients with
advanced cancerb
• 79% solid
tumors
• 9 men; mean
age 59.5 years
• 15 women;
mean age 56
years

• Reiki (n=11)
• Rest (n=13)

• Pain

•
•
•
•

Reiki
Olson, K
(2003)

7 days

VAS
SBP/DBP
HR
RR

• Breathing subscale of VAS
improved with reflexology (mean
change 2.2; P<0.05 between groups)
• Overall improvement in QoL scores
improved for EG (P=0.004 between
groups; data not provided)
• HADS scores remained stable for
both study groups from baseline to
six weeks
• No significant difference between
groups except for improvement in
appetite and mobility in foot
massage group
• Improvement with EG reported for
pain (P=0.035), drop in DBP
(P=0.005) and HR (P=0.005)
compared to rest on day one
• No significant difference in pain or
median morphine equivalent dose
from day one to day seven between
study groups
• SSC: 100 subjects to detect a 20%
reduction in VAS pain score

Table 2. Summary of Articles Included in Systematic Review. This chart outlines characteristics of studies included in the systematic review.
AUC=Area Under Curve. BPI=Brief Pain Inventory. C=Controlled. CG=Control Group. CS=Crossover Study. DB=Double Blinding. DBP=Diastolic Blood Pressure. EG=Experimental Group.
ESAS=Edmonton Symptom Assessment Scale. HADS=Hospital Anxiety and Depression Scale. HIV/AIDS=Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. HR=Heart
Rate. MPAC=Memorial Pain Assessment Card. MSE=Mean Squared Errors. MVQOLI=Missoula-VITAS Quality of Life Index. MYMOP=Measure Your Medical Outcomes Profile Scores. NB=No
Blinding. NRS=Numerical Rating Scale. POMS=Profile of Mood State. QoL=Quality of Life. R=Randomized. RR=Respiratory Rate. RSCL=Rotterdam Symptom Checklist. SBP=Systolic Blood
Pressure. SOB=Shortness of Breath. SSC=Sample Size Calculation. SB=Single Blind. STAI=State Trait Anxiety Inventory. VAS=Visual Analog Scale. VSH=Verran and Snyder-Halpern sleep scale
a

=Baseline characteristics are listed as reported in study (i.e. Some studies analyzed characteristics of the whole study population while other studies analyzed characteristics of individual study
groups)
b=Number represents evaluable participants and does not include excluded participants originally randomized

Supplemental Table 1
Description of Validated Assessment Tools used in Studies
Tool
ESAS1

Use
Assess nine common
symptoms experienced by
patients receiving palliative
care using VAS

Graham’s QoL Tool2

Measure perceived QoL in
patients with melanoma

•
•
•
•
•
•
•
•
•
•
•
•

Subscales
Pain
Activity
Nausea
Depression
Anxiety
Drowsiness
Appetite
Wellbeing
Shortness of Breath
GWBS
CQLS
SCQLS

Scores
• 0–100mm
• 0 – Symptom is absent
• 100 – Worst possible
severity
Higher numbers indicate worse
outcomes

GWBS:
• 1–10
• 1 – “poorer than most”
• 10 – “very much better than
most”
CQLS
• 1–10
• 1 – Poor
• 10 – Excellent
SCQLS:
• 1–10
• 1 – Not at all satisfied
• 10 – Very satisfied
Lower numbers indicate worse
outcomes

HADS3

Detect states of depression and
anxiety in the setting of a
hospital medical outpatient
clinic

• Anxiety
• Depression

Anxiety/Depression Subscales
• 1–3
• 1 – Not at all
• 3 – Very often
Overall:
• 0–7 = Normal
• 8–10 = Mild
• 11–14 = Moderate
• 15–21 = Severe
Higher numbers indicate worse
outcomes

McGill QoL Questionnaire4

MYMOP/MYMOP25

Assess QoL in patients with a
life-threatening disease in a
palliative care setting

•
•
•
•

Evaluate patient-generated
measures over time

• Symptom 1
• Symptom 2
• Activity

Physical symptoms
Psychological symptoms
Existential wellbeing
Support

• 0–10
• 0 – Least desirable
situation
• 10 – Most desirable
situation
Lower numbers indicate worse
outcomes
• 0–6
• 0 – As good as it could be
• 6 – As bad as it could be
Higher numbers indicate worse
outcomes

MPAC6

Assess pain and distress in
patients with cancer

•
•
•
•

Mood Scale
Pain Scale
Pain Description Scale
Relief Scale

Mood Scale
• Worst mood to Best mood
Lower scores indicate worse
outcomes

Pain Scale
• Least possible pain to Worst
possible pain
Higher numbers indicate worse
outcomes
Pain Description Scale
• No pain
• Weak
• Mild
• Just noticeable
• Moderate
• Strong
• Severe
• Excruciating
Relief Scale
• No relief of pain to Complete
relief of pain
Lower scores indicate worse
outcomes
MSAS7

MVQOLI8

NRS9

POMS10

Evaluate symptom prevalence,
characteristics, and distress in
patients with cancer

• Global Distress Index
• MSAS Psychological
• MSAS Physiological

Assess QoL measures in
patients with terminal illness

•
•
•
•
•
•

Measure severity of symptoms
being assessed

• None

• 0–#
• 0 – Not at all
• # – Worst
Higher numbers indicate worse
outcomes

Assess transient, fluctuating
feelings and enduring affect
states

• TMD
• Tension-anxiety
• Depression
• Anger-hostility
• Vigor-activity
• Fatigue

TMD

Global
Symptom
Function
Interpersonal
Wellbeing
Transcendent

• 0–4
• 0 – Not at all
• 4 – Very
severe/much/often
Higher numbers indicate worse
outcomes
• Agree Strongly to
Neutral/Disagree Strongly
Outcome depends on statement to
which answer is given

• 0–6
• 0 – No disturbance
• 76 – More disturbance

RSCL11

Assess QoL in patients with
cancer

•
•
•
•

• Confusion-bewilderment

Higher numbers indicate worse
outcomes

Physical Symptom Distress
Psychological Distress
Activity Level
Overall valuation of life

Physical Symptom
Distress/Psychological Distress
• 1–4
• 1 – Not at all
• 4 – Very much
Higher numbers indicate higher
level of burden or impairment

Activity Level
• 1–4
• 1 – Not at all
• 4 – Very much
Overall valuation of life
• 1–7
• 1 – Excellent
• 7 – Very poor
Higher numbers indicate worse
outcomes
STAI12

Measure presence and severity
of current symptoms of
anxiety

• State Anxiety Inventory Scale
• Trait Anxiety Inventory Scale

State Anxiety Inventory Scale
• 1–4
• 1 – Not at all
• 4 – Very much so
Trait Anxiety Inventory Scale
• 1–4
• 1 – Almost never
• 4 – Almost always
Higher numbers indicate worse
outcomes

VAS13

Measure severity of
symptom(s) being assessed

• None

• 0–100mm
• 0 – Least possible
• 100 – Worst possible
Higher number indicates worse
outcomes
(Length of scale may vary)

VSH14

Measure previous night’s sleep
characteristics

• Sleep Disturbance
• Effectiveness
• Supplementation

Sleep Disturbance/Effectiveness
• 0–100mm
• 0 – Better sleep
• 100 – Worse sleep

Higher numbers indicate worse
outcomes
Supplementation
• 0–100mm
• 0 – Worse sleep
• 100 – Better sleep
Lower numbers indicate worse
outcomes

Table 2. Description of Validated Assessment Tools used in Studies. Table that describes various assessment tools that have been validated in
literature. A few studies used tools specific to their institution which could not be found in literature or full access was unavailable. Variations of the
listed tools may have been adopted in studies.
CQLS=Current Quality of Life Scale. ESAS=Edmonton Symptom Assessment Scale. GWBS=Global Well Being Scale. HADS=Hospital Anxiety
and Depression Scale. MYMOP/MYMOP2=Measure Your Medical Outcomes Profile (Version 2). MPAC=Memorial Pain Assessment Card.
MSAS=Memorial Symptom Assessment Scale. MVQOLI=Missoula-VITAS Quality of Life Index. NRS=Numerical Rating Scale. POMS=Profile of
Mood States. QoL=Quality of Life. RSCL=Rotterdam Symptom Checklist. SCQLS=Satisfaction with Current Quality of Life Scale. STAI=StateTrait Anxiety Inventory Scale. TMD= Total Mood Disturbance. VAS=Visual Analogue Scale. VSH=Verran and Snyder-Halpern.
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Figure 1. Flow Diagram of Steps in Systematic Review. Outlines steps taken and number of studies excluded and included in each step.

Supplemental Figure 1
Complementary and/or Alternative Medicine Definitions
Embase Emtree
Alternative Medicine
Aromatherapy
Horticultural therapy
Iridology
Mesotherapy
Moxibustion
Orthomolecular medicine
Reiki
Shamanism
Spiritual healing
Therapy with helminths

CINAHL Headings
Alternative Therapies
MEDLINE MeSH
Alternative Medical Systems (+3)
Complementary Therapies
Acupuncture (+4)
Acupuncture Therapy
Meridians
Acupuncture Analgesia
Anthroposophy
Acupuncture, Ear
Chiropractic (+1)
Electroacupuncture
Homeopathy
Meridians +
Medicine, Herbal (+1)
Moxibustion
Medicine, Oriental (+7)
Anthroposophy
Medicine, Ayurvedic
Auriculotherapy (+1)
Medicine, Oriental
Diffuse Noxious Inhibitory Control
Acupressure (+2)
Holistic Health (+1)
Medicine, Chinese (+3)
Homeopathy
Acupuncture (+4)
Horticultural Therapy
PsycINFO Thesaurus
Naturopathy
Medicine, Traditional (+9)
Alternative Medicine
Apitherapy
Mesotherapy
Biofeedback Training
Aromatherapy
Mind-Body Therapies
Dietary Supplements
Auriculotherapy (+1)
Aromatherapy
Holistic Health
Bioelectromagnetic Application (+9)
Biofeedback, Psychology +
Hypnotherapy
Bioenergy Therapies
Breathing Exercises +
Massage
Reiki
Hypnosis +
Medical Treatment (General)
Therapeutic Touch
Imagery (Psychotherapy)
Medicinal Herbs and Plants
Bowen
Technique
Laughter Therapy
Meditation
Butekyo Method
Meditation
Mind Body Therapy
Detoxification, Alternative Therapy (+2)
Mental Healing
Osteopathic Medicine
Life Style Changes
Psychodrama +
Phototherapy
Manual Therapy (+4)
Psychophysiology
Physical Treatment Methods
Chiropractic (+5)
Relaxation Therapy
Preventive Medicine
Massage (+5)
Tai Ji
Shock Therapy
Reflexology
Therapeutic Touch
Transcultural Psychiatry
Mind Body Techniques
Yoga
Guided Imagery
Musculoskeletal Manipulations (+4)
Hypnosis (+1)
Therapy, Soft Tissue +
Meditation
Naturopathy
Music Therapy
Organotherapy (+1)
Relaxation Techniques (+2)
Phytotherapy (+2)
Spiritual Healing (+1)
Reflexotherapy
Tai Chi
Sensory Art Therapies
Yoga (+1)
Acoustic Stimulation
Natural and Biologically Based Therapies (+2)
Aromatherapy
Medicine, Herbal
Art Therapy
Pharmacological and Biological Treatments
Color Therapy
Rejuvenation
Dance Therapy
Wilderness Experience
Music Therapy
Play Therapy
Speleotherapy
Spiritual Therapies (+10)
Supplemental Figure 1. Complementary and/or Alternative Medicine Definitions. This figure provides examples of therapies according to each database’s definition of CAM. This table is not allinclusive. Includes MEDLINE’s Medical Subject Heading (MeSH) Definition of Complementary therapies, Embase’s Emtree Definition of Alternative therapies, PsycINFO’s Thesaurus Definition of
Alternative therapies and Cumulative Index of Nursing and Allied Health Literature (CINAHL)’s Headings Definition of Complementary therapies.

